BRIEF published on 05/20/2024 at 22:19, 1 year 6 months ago Meta Materials Announces Update on Naked Short Selling Investigation Meta Materials Naked Short Selling Market Manipulation Legal Investigation NASDAQ:MMAT
PRESS RELEASE published on 05/20/2024 at 22:14, 1 year 6 months ago Meta Materials Announces Update on Naked Short Selling Investigation Meta Materials Inc. provides an update on short selling investigation, identifying meritorious claims for market manipulation. Lawyers conclude exhaustive investigation Meta Materials Inc. Market Manipulation Short Selling Investigation Lawyers Stock Manipulation
BRIEF published on 05/03/2024 at 22:10, 1 year 7 months ago Meta Materials Announces Major Workforce Reduction Strategic Alternatives Meta Materials Inc. Liquidity Challenges Financial Hardship Workforce Reduction
PRESS RELEASE published on 05/03/2024 at 22:05, 1 year 7 months ago Meta Materials Announces Workforce Reduction Meta Materials Inc. announced an 80% workforce reduction due to financial challenges. The company is exploring strategic alternatives, including asset divestiture and additional financing Strategic Alternatives Meta Materials Inc. Financial Challenges Workforce Reduction Additional Financing
BRIEF published on 03/28/2024 at 21:30, 1 year 8 months ago Meta Materials Announces Upcoming Corporate Update Webcast Advanced Materials Meta Materials Inc. Nanotechnology Corporate Webcast Sustainable Science
PRESS RELEASE published on 03/28/2024 at 21:25, 1 year 8 months ago Meta Materials Schedules Corporate Update Webcast Meta Materials Inc. (NASDAQ: MMAT) will host a corporate update webcast on April 3, 2024, at 4:30 PM EDT. The event aims to showcase Meta's advancements in advanced materials and nanotechnology Advanced Materials Meta Materials Inc. Webcast Corporate Update Nanotechnology
BRIEF published on 03/06/2024 at 22:05, 1 year 8 months ago Meta Materials Seeks Shareholder Approval for Share Increase to Fuel Growth Shareholder Approval Commercialization Nanotechnology Meta Materials Stock Issuance
PRESS RELEASE published on 03/06/2024 at 22:00, 1 year 8 months ago Meta Materials Releases Letter to Shareholders Regarding Upcoming Special Meeting Meta Materials Inc. requests shareholder approval for an increase in common shares to support commercialization plans and partnerships in advanced materials and nanotechnology sectors Common Shares Advanced Materials Shareholder Approval Meta Materials Inc. Commercialization
PRESS RELEASE published on 02/20/2024 at 14:00, 1 year 9 months ago Meta Materials Announces Pricing of $3.4 Million Registered Direct Offering Priced At-the-Market Meta Materials Inc. announces $3.4 million common stock offering with an institutional investor. Proceeds to fund technology commercialization and sales efforts in various sectors Technology Commercialization Meta Materials Inc. Common Stock Offering NPORE VLEPSIS
BRIEF published on 02/20/2024 at 14:00, 1 year 9 months ago Meta Materials Inc. Announces Direct Placement Financing Warrants Shares Meta Materials Inc Direct Placement Nanotechnology
Published on 12/05/2025 at 02:35, 3 hours 39 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 14 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 9 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 14 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 43 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 23 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 48 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 59 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 3 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 14 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 29 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 30 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 13 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
